Umbilical Cord Blood Banking in Saudi Arabia: Benefits, Costs, and Guidelines

Introduction to Umbilical Cord Blood Stem Cells

With the rapid advancement of regenerative medicine in the Kingdom of Saudi Arabia, cord blood banking and donation have become significant topics for expectant parents during pregnancy care. Umbilical cord blood is rich in hematopoietic stem cells, which have the unique ability to develop into various blood cells, making them a valuable resource for treating numerous life-threatening diseases.

This medical guide, provided by LahaLak medical platform, aims to deliver objective, scientifically backed information regarding cord blood collection, the differences between public and private banking, and the regulatory and medical conditions in Saudi Arabia.

What is Cord Blood and How is it Collected?

Cord blood is the blood remaining in the umbilical cord and placenta after the birth of the baby. These umbilical cord stem cells are biologically younger and less mature than adult bone marrow stem cells, which significantly reduces the risk of rejection during transplantation.

The Collection Process During Delivery

The collection of cord blood is a safe, painless, and non-invasive procedure that poses no risk to either the mother or the newborn, whether the delivery is a vaginal birth or a cesarean birth. The process involves the following steps:

• Immediately after the baby is delivered and the cord is clamped and cut, the obstetrician or midwife inserts a sterile needle into the umbilical vein.
• The blood drains naturally into a collection bag containing an anticoagulant solution.
• The entire procedure takes less than 10 minutes and does not interfere with the active management of labor or delivery.
• The collected sample is then sealed, placed in a temperature-controlled container, and transported to the laboratory for testing and cryopreservation.

Public vs. Private Cord Blood Banking

Expectant parents in Saudi Arabia have two distinct pathways for preserving umbilical cord blood, each serving different purposes and carrying different financial implications:

1. Public Cord Blood Banking (Donation)

Public banking involves donating the cord blood to a public registry where it is processed and stored for anyone in need of a compatible stem cell transplant. In Saudi Arabia, the National Cord Blood Bank at the King Abdullah International Medical Research Center (KAIMRC) and the advanced stem cell services at King Faisal Specialist Hospital and Research Centre (KFSH&RC) are leading institutions in this field. Public donation is completely free of charge and contributes to saving lives globally.

2. Private Cord Blood Banking (Family Storage)

Private banking involves storing the cord blood in a commercial facility for the exclusive use of the donor child or compatible family members (such as siblings). This option requires paying an initial collection and processing fee, followed by annual storage fees.

Comparison Between Public and Private Cord Blood Banks

The following table outlines the key differences to help families make an informed decision:

Proven Medical Uses of Cord Blood Stem Cells

Stem cells derived from cord blood are currently approved by global medical authorities and the Saudi Food and Drug Authority (SFDA) to treat over 80 life-threatening conditions, including:

• Hematological malignancies such as leukemia and lymphoma.
• Bone marrow failure syndromes and inherited red blood cell disorders like sickle cell anemia and thalassemia.
• Severe combined immunodeficiency (SCID) and other genetic immune system disorders.
• Certain metabolic disorders.

Conditions with Insufficient Scientific Evidence

It is clinically important to clarify that some commercial entities promote cord blood storage for conditions that are still experimental. Currently, there is insufficient clinical evidence to support the routine use of cord blood for:

• Autism spectrum disorders.
• Cerebral palsy and spinal cord injuries.
• Type 1 diabetes.
• Alzheimer's disease and neurodegenerative disorders.

Medical societies emphasize that using a child's own cord blood to treat an inherited genetic disease is often not viable because the stored stem cells carry the same genetic mutation. In such cases, healthy donor cells from a public bank are clinically preferred.

Eligibility Criteria and Maternal Screening

To ensure the safety and viability of the stored stem cells, both the mother and the sample must meet strict medical standards:

• Maternal Health History: Absence of hereditary blood disorders or active immunological conditions.
• Infectious Disease Screening: The mother's blood is tested for infectious diseases, including HIV, Hepatitis B and C, and syphilis.
• Pregnancy and Labor Status: Absence of active maternal infections during labor.

Timing and Coordination with the Maternity Hospital

Proper planning is essential to ensure a successful collection process:

• When to Register: Registration with the chosen public or private bank should ideally occur during the second trimester or early third trimester (between weeks 28 and 34 of pregnancy).
• The Collection Kit: For private banking, the family receives a collection kit that must be brought to the hospital on the day of delivery.
• Informing the Care Team: Inform your obstetrician and delivery team of your decision to collect cord blood immediately upon admission to the labor ward.

Cost Components of Private Stem Cell Preservation

If a family chooses private banking, they should carefully review the contract terms and cost breakdown:

• Collection Kit Fee: The cost of the sterile medical kit and materials.
• Medical Courier/Transport: The cost of transporting the sample under strict temperature controls to the processing laboratory.
• Processing and Testing: Fees for isolating the stem cells, testing for viability, and screening for contamination.
• Annual Storage Fees: The cost of maintaining the sample in liquid nitrogen, which can be paid annually or as a multi-year prepaid package (usually for 15 to 25 years).

What If the Cell Count is Insufficient?

In some instances, laboratory analysis may reveal that the volume of collected blood or the total nucleated cell count is below the minimum threshold required for a successful clinical transplant. In such cases:

• The bank will notify the parents that the sample is not viable for therapeutic storage.
• With parental consent, the sample may be donated for medical research.
• For private banking, a portion of the fees (such as prepaid storage fees) is typically refunded, subject to the terms of the signed contract.

LahaLak medical team advises consulting your healthcare provider to discuss the clinical utility of cord blood banking and to carefully review all policies before making a final decision.